Geranylgeranylation: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== | {{Infobox medical condition | ||
| name = Geranylgeranylation | |||
| image = <!-- Image removed --> | |||
| caption = <!-- Caption removed --> | |||
| field = Biochemistry | |||
}} | |||
Geranylgeranylation is | '''Geranylgeranylation''' is a form of [[prenylation]], a post-translational modification of proteins. This process involves the addition of a [[geranylgeranyl group]] to a [[cysteine]] residue at or near the C-terminus of a protein. Geranylgeranylation is crucial for the proper functioning of a variety of proteins, including members of the [[Rho family of GTPases]], which are involved in [[cell signaling]] and [[cytoskeletal dynamics]]. | ||
== Mechanism == | |||
Geranylgeranylation is catalyzed by the enzyme [[geranylgeranyltransferase]]. This enzyme transfers a geranylgeranyl moiety from [[geranylgeranyl pyrophosphate]] (GGPP) to the target protein. The modification typically occurs at a [[CAAX motif]], where "C" is a cysteine, "A" is an aliphatic amino acid, and "X" is any amino acid that determines the type of prenylation. | |||
The | == Biological Significance == | ||
The addition of a geranylgeranyl group increases the hydrophobicity of the protein, facilitating its association with cell membranes. This membrane association is essential for the protein's biological activity. For example, geranylgeranylation of [[Rho GTPases]] is necessary for their role in [[regulating the actin cytoskeleton]], which is important for [[cell migration]], [[cell division]], and [[cell shape]]. | |||
== | == Clinical Implications == | ||
Defects in geranylgeranylation can lead to various diseases. For instance, improper prenylation of proteins has been implicated in certain [[cancer]]s and [[cardiovascular diseases]]. Inhibitors of geranylgeranyltransferase are being explored as potential therapeutic agents for these conditions. | |||
== See Also == | |||
* [[Prenylation]] | * [[Prenylation]] | ||
* [[Farnesylation]] | * [[Farnesylation]] | ||
* [[Protein | * [[Protein modification]] | ||
== References == | == References == | ||
<references /> | |||
== External Links == | |||
* [Geranylgeranylation on Wikipedia](https://en.wikipedia.org/wiki/Geranylgeranylation) | |||
[[Category:Biochemistry]] | |||
[[Category: | |||
[[Category:Post-translational modification]] | [[Category:Post-translational modification]] | ||
[[Category:Cell | [[Category:Cell signaling]] | ||
Latest revision as of 20:21, 30 December 2024
| Geranylgeranylation | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | N/A |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | N/A |
| Risks | N/A |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | N/A |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Geranylgeranylation is a form of prenylation, a post-translational modification of proteins. This process involves the addition of a geranylgeranyl group to a cysteine residue at or near the C-terminus of a protein. Geranylgeranylation is crucial for the proper functioning of a variety of proteins, including members of the Rho family of GTPases, which are involved in cell signaling and cytoskeletal dynamics.
Mechanism[edit]
Geranylgeranylation is catalyzed by the enzyme geranylgeranyltransferase. This enzyme transfers a geranylgeranyl moiety from geranylgeranyl pyrophosphate (GGPP) to the target protein. The modification typically occurs at a CAAX motif, where "C" is a cysteine, "A" is an aliphatic amino acid, and "X" is any amino acid that determines the type of prenylation.
Biological Significance[edit]
The addition of a geranylgeranyl group increases the hydrophobicity of the protein, facilitating its association with cell membranes. This membrane association is essential for the protein's biological activity. For example, geranylgeranylation of Rho GTPases is necessary for their role in regulating the actin cytoskeleton, which is important for cell migration, cell division, and cell shape.
Clinical Implications[edit]
Defects in geranylgeranylation can lead to various diseases. For instance, improper prenylation of proteins has been implicated in certain cancers and cardiovascular diseases. Inhibitors of geranylgeranyltransferase are being explored as potential therapeutic agents for these conditions.
See Also[edit]
References[edit]
<references />
External Links[edit]
- [Geranylgeranylation on Wikipedia](https://en.wikipedia.org/wiki/Geranylgeranylation)